Scarica l'app Stockscreener
50.24
2.01%
0.99
Dopo l'orario di chiusura:
49.48
-0.76
-1.51%
Precedente Chiudi:
$49.25
Aprire:
$49.05
Volume 24 ore:
1.08M
Relative Volume:
0.63
Capitalizzazione di mercato:
$6.58B
Reddito:
-
Utile/perdita netta:
$-507.65M
Rapporto P/E:
-10.92
EPS:
-4.6
Flusso di cassa netto:
$-616.24M
1 W Prestazione:
+1.43%
1M Prestazione:
+18.97%
6M Prestazione:
+54.39%
1 anno Prestazione:
-45.21%
Intervallo 1D:
$48.79
$50.27
Intervallo di 1 settimana:
$47.02
$50.27
Portata 52W:
$27.66
$94.76
Vaxcyte Inc Stock (PCVX) Company Profile
Nome
Vaxcyte Inc
Settore
Industria
Telefono
650-837-0111
Indirizzo
825 INDUSTRIAL ROAD, STE. 300, SAN CARLOS, CA
Confronta PCVX con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
PCVX
Vaxcyte Inc
|
50.24 | 6.45B | 0 | -507.65M | -616.24M | -4.60 |
|
VRTX
Vertex Pharmaceuticals Inc
|
429.82 | 107.58B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
787.32 | 80.03B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
429.80 | 57.37B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
917.93 | 55.83B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
209.02 | 44.13B | 447.02M | -1.18B | -906.14M | -6.1812 |
Vaxcyte Inc Stock (PCVX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-09-12 | Iniziato | Goldman | Neutral |
| 2025-04-22 | Iniziato | Cantor Fitzgerald | Overweight |
| 2024-12-20 | Iniziato | Goldman | Buy |
| 2023-12-07 | Iniziato | Mizuho | Buy |
| 2023-04-18 | Iniziato | TD Cowen | Outperform |
| 2023-01-03 | Reiterato | Needham | Buy |
| 2022-12-15 | Iniziato | Guggenheim | Buy |
| 2022-11-17 | Iniziato | BTIG Research | Buy |
| 2021-12-29 | Ripresa | Jefferies | Buy |
| 2021-06-24 | Ripresa | Jefferies | Buy |
| 2020-07-07 | Iniziato | BofA Securities | Buy |
| 2020-07-07 | Iniziato | Cantor Fitzgerald | Overweight |
| 2020-07-07 | Iniziato | Needham | Buy |
Mostra tutto
Vaxcyte Inc Borsa (PCVX) Ultime notizie
EBIT per share of Vaxcyte, Inc. – DUS:5VA - TradingView
Mizuho Securities Sticks to Their Buy Rating for Vaxcyte (PCVX) - The Globe and Mail
Vaxcyte (PCVX): Evaluating Valuation After a 48% Three-Month Share Price Rebound - Yahoo Finance
How Vaxcyte Inc. stock reacts to Fed rate cutsWeekly Trade Report & Free Technical Pattern Based Buy Signals - newser.com
Is Vaxcyte Inc. stock vulnerable to regulatory risksEarnings Growth Report & Risk Managed Investment Entry Signals - newser.com
Will Vaxcyte Inc. stock continue upward momentumQuarterly Trade Review & Accurate Trade Setup Notifications - newser.com
Is Vaxcyte Inc. (5VA) stock a top hedge fund pickJuly 2025 Action & Momentum Based Trading Ideas - newser.com
Vaxcyte stock price target raised to $77 from $60 at Leerink Partners By Investing.com - Investing.com South Africa
Vaxcyte stock price target raised to $77 from $60 at Leerink Partners - Investing.com Australia
PCVX: 31-Valent vaccine nears phase III, targeting major market growth and expanded global demand - TradingView
Vaxcyte (PCVX) Price Target Decreased by 17.52% to 83.49 - MSN
What analyst consensus says on Vaxcyte Inc. stockTrade Entry Report & High Conviction Trade Alerts - newser.com
(PCVX) and the Role of Price-Sensitive Allocations - news.stocktradersdaily.com
Can momentum traders help lift Vaxcyte Inc.July 2025 Action & Precise Swing Trade Entry Alerts - newser.com
Is Vaxcyte Inc. stock poised for growthEarnings Trend Report & Daily Technical Forecast Reports - newser.com
Will Vaxcyte Inc. benefit from macro trendsPortfolio Risk Summary & Safe Capital Allocation Plans - newser.com
Vaxcyte, Inc.Common Stock (NQ: PCVX - Markets Financial Content
Vaxcyte Inc Stock Analysis and ForecastStock Split Announcements & High Profit Portfolio Growth - earlytimes.in
Vaxcyte stock up on results from mid-stage trial of its pneumococcal vaccine - MSN
Vaxcyte Inc. (PCVX) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Vaxcyte (BIT:1PCVX) Price Target Decreased by 15.42% to 72.37 - Nasdaq
Is Vaxcyte’s (PCVX) Aggressive R&D Spend Still Justified Amid Widening Losses? - simplywall.st
Should you wait for a breakout in Vaxcyte Inc.July 2025 Review & High Conviction Investment Ideas - newser.com
Quantitative breakdown of Vaxcyte Inc. recent move2025 Technical Overview & Real-Time Market Sentiment Alerts - newser.com
Has Vaxcyte Inc. found a price floorBond Market & Smart Investment Allocation Insights - newser.com
Can Vaxcyte Inc. (5VA) stock attract analyst upgrades2025 Performance Recap & AI Powered Buy and Sell Recommendations - newser.com
Using data tools to time your Vaxcyte Inc. exitChart Signals & Daily Market Momentum Tracking - newser.com
Vaxcyte, Inc. (5VA.F) Stock Price, News, Quote & History - Yahoo! Finance Canada
Will Vaxcyte Inc. stock benefit from commodity prices2025 Price Momentum & Risk Controlled Stock Alerts - newser.com
Vaxcyte’s Stock Juggle: Opportunity or Risk? - StocksToTrade
What moving averages say about Vaxcyte Inc.Market Rally & Reliable Breakout Forecasts - newser.com
Vaxcyte Inc Azioni (PCVX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.53%
1.88%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):